Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q80558724)
Watch
English
[Immunosuppression with monoclonal antibodies in multiple sclerosis]
scientific article published on 01 June 2007
In more languages
default for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17607190
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17607190%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 January 2020
review article
1 reference
stated in
Europe PubMed Central
title
[Immunosuppression with monoclonal antibodies in multiple sclerosis]
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17607190
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17607190%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 January 2020
main subject
multiple sclerosis
1 reference
based on heuristic
inferred from title
monoclonal antibody
1 reference
based on heuristic
inferred from title
author
Helene Zephir
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17607190
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17607190%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 January 2020
author name string
P Vermersch
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17607190
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17607190%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 January 2020
publication date
1 June 2007
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17607190
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17607190%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 January 2020
published in
Revue neurologique
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17607190
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17607190%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 January 2020
volume
163
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17607190
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17607190%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 January 2020
issue
6-7
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17607190
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17607190%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 January 2020
page(s)
682-687
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17607190
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17607190%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 January 2020
cites work
Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990480-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990480-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990480-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990480-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990480-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990480-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Progressive multifocal leukoencephalopathy in a patient treated with natalizumab
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990480-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990480-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990480-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natalizumab: alpha 4-integrin antagonist selective adhesion molecule inhibitors for MS.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990480-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990480-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990480-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990480-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
α4Integrins as Therapeutic Targets in Autoimmune Disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990480-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0035-3787%2807%2990480-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0035-3787(07)90480-4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17607190
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17607190%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 January 2020
PubMed publication ID
17607190
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17607190
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17607190%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit